COVID-19 Impact on Psoriasis Drugs Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Psoriasis Drugs Industry
1.7 COVID-19 Impact: Psoriasis Drugs Market Trends
2 Global Psoriasis Drugs Quarterly Market Size Analysis
2.1 Psoriasis Drugs Business Impact Assessment - COVID-19
2.1.1 Global Psoriasis Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Psoriasis Drugs Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Psoriasis Drugs Quarterly Market Size, 2019 VS 2020
3.2 By Players, Psoriasis Drugs Headquarters and Area Served
3.3 Date of Key Players Enter into Psoriasis Drugs Market
3.4 Key Players Psoriasis Drugs Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Psoriasis Drugs Segments, By Type
4.1 Introduction
1.4.1 Tumor Necrosis Factor Inhibitor
1.4.2 Interleukin Inhibitors
1.4.3 Others
4.2 By Type, Global Psoriasis Drugs Market Size, 2019-2021
5 Impact of Covid-19 on Psoriasis Drugs Segments, By Application
5.1 Overview
5.5.1 Topicals
5.5.2 Systemic
5.5.3 Biologics
5.2 By Application, Global Psoriasis Drugs Market Size, 2019-2021
5.2.1 By Application, Global Psoriasis Drugs Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 AbbVie
7.1.1 AbbVie Business Overview
7.1.2 AbbVie Psoriasis Drugs Quarterly Revenue, 2020
7.1.3 AbbVie Psoriasis Drugs Product Introduction
7.1.4 AbbVie Response to COVID-19 and Related Developments
7.2 Amgen
7.2.1 Amgen Business Overview
7.2.2 Amgen Psoriasis Drugs Quarterly Revenue, 2020
7.2.3 Amgen Psoriasis Drugs Product Introduction
7.2.4 Amgen Response to COVID-19 and Related Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Business Overview
7.3.2 Johnson & Johnson Psoriasis Drugs Quarterly Revenue, 2020
7.3.3 Johnson & Johnson Psoriasis Drugs Product Introduction
7.3.4 Johnson & Johnson Response to COVID-19 and Related Developments
7.4 Novartis
7.4.1 Novartis Business Overview
7.4.2 Novartis Psoriasis Drugs Quarterly Revenue, 2020
7.4.3 Novartis Psoriasis Drugs Product Introduction
7.4.4 Novartis Response to COVID-19 and Related Developments
7.5 Eli Lilly & Company
7.5.1 Eli Lilly & Company Business Overview
7.5.2 Eli Lilly & Company Psoriasis Drugs Quarterly Revenue, 2020
7.5.3 Eli Lilly & Company Psoriasis Drugs Product Introduction
7.5.4 Eli Lilly & Company Response to COVID-19 and Related Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Business Overview
7.6.2 AstraZeneca Psoriasis Drugs Quarterly Revenue, 2020
7.6.3 AstraZeneca Psoriasis Drugs Product Introduction
7.6.4 AstraZeneca Response to COVID-19 and Related Developments
7.7 Celgene Corporation
7.7.1 Celgene Corporation Business Overview
7.7.2 Celgene Corporation Psoriasis Drugs Quarterly Revenue, 2020
7.7.3 Celgene Corporation Psoriasis Drugs Product Introduction
7.7.4 Celgene Corporation Response to COVID-19 and Related Developments
7.8 UCB
7.8.1 UCB Business Overview
7.8.2 UCB Psoriasis Drugs Quarterly Revenue, 2020
7.8.3 UCB Psoriasis Drugs Product Introduction
7.8.4 UCB Response to COVID-19 and Related Developments
7.9 Merck
7.9.1 Merck Business Overview
7.9.2 Merck Psoriasis Drugs Quarterly Revenue, 2020
7.9.3 Merck Psoriasis Drugs Product Introduction
7.9.4 Merck Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Psoriasis Drugs Assessment
Table 9. COVID-19 Impact: Psoriasis Drugs Market Trends
Table 10. COVID-19 Impact Global Psoriasis Drugs Market Size
Table 11. Global Psoriasis Drugs Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Psoriasis Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Psoriasis Drugs Market Growth Drivers
Table 14. Global Psoriasis Drugs Market Restraints
Table 15. Global Psoriasis Drugs Market Opportunities
Table 16. Global Psoriasis Drugs Market Challenges
Table 17. By Players, Psoriasis Drugs Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Psoriasis Drugs Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Psoriasis Drugs Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Psoriasis Drugs Market
Table 21. Key Players Psoriasis Drugs Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Psoriasis Drugs Market Size 2019-2021, (US$ Million)
Table 24. Global Psoriasis Drugs Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Psoriasis Drugs Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Psoriasis Drugs Market Size, 2019-2021 (US$ Million)
Table 57. AbbVie Business Overview
Table 58. AbbVie Psoriasis Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. AbbVie Psoriasis Drugs Product
Table 60. AbbVie Response to COVID-19 and Related Developments
Table 61. Amgen Business Overview
Table 62. Amgen Psoriasis Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Amgen Psoriasis Drugs Product
Table 64. Amgen Response to COVID-19 and Related Developments
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Psoriasis Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Johnson & Johnson Psoriasis Drugs Product
Table 68. Johnson & Johnson Response to COVID-19 and Related Developments
Table 69. Novartis Business Overview
Table 70. Novartis Psoriasis Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Novartis Psoriasis Drugs Product
Table 72. Novartis Response to COVID-19 and Related Developments
Table 73. Eli Lilly & Company Business Overview
Table 74. Eli Lilly & Company Psoriasis Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Eli Lilly & Company Psoriasis Drugs Product
Table 76. Eli Lilly & Company Response to COVID-19 and Related Developments
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Psoriasis Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. AstraZeneca Psoriasis Drugs Product
Table 80. AstraZeneca Response to COVID-19 and Related Developments
Table 81. Celgene Corporation Business Overview
Table 82. Celgene Corporation Psoriasis Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Celgene Corporation Psoriasis Drugs Product
Table 84. Celgene Corporation Response to COVID-19 and Related Developments
Table 85. UCB Business Overview
Table 86. UCB Psoriasis Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. UCB Psoriasis Drugs Product
Table 88. UCB Response to COVID-19 and Related Developments
Table 89. Merck Business Overview
Table 90. Merck Psoriasis Drugs Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Merck Psoriasis Drugs Product
Table 92. Merck Response to COVID-19 and Related Developments
List of FiguresFigure 1. Psoriasis Drugs Product Picture
Figure 2. Psoriasis Drugs Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Psoriasis Drugs Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Psoriasis Drugs Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Psoriasis Drugs Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Psoriasis Drugs Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Psoriasis Drugs Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Psoriasis Drugs Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Psoriasis Drugs Market Size Market Share, 2019-2021